Search

everythinglearnresearchcommunity

for

Search:↓

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride potentially treats hair loss by reducing DHT production.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Higher androgen levels do not cause baldness in men.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

The modified Direct Hair Transplantation method is effective for treating baldness with better graft survival and less damage than standard techniques.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Antiandrogen therapy helps treat genetic hair loss.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Genomic approach finds new possible treatments for hair loss.

Vitamin C derivative reduces hair loss-related protein in cells.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

Hsc70 protein may influence hair growth by responding to androgens.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Korean and Caucasian men with male pattern baldness have different hair steroid levels.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.